Research Says Allergy Medications Can Fight Multiple Sclerosis
This research is the first of its kind
Ari Green, MD, is the principal investigator of the trial and explained the importance of the study: “To the best of our knowledge this is the first time a therapy has been able to reverse deficits caused by MS. It's not a cure, but it's a first step towards restoring brain function to the millions who are affected by this chronic, debilitating disease."
